An in vitro patient-derived intestinal epithelial monolayer model that replicates human gut physiology for studying epithelial barrier function and drug effects in inflammatory bowel disease (IBD).

A service using PDO Monolayer to assess epithelial barrier function, cytotoxicity, and cytokine release for IBD drug discovery and development.